Enveric Biosciences (ENVB) Income Statement: Revenue & Earnings

Enveric Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Enveric Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.34	0.00	0.00	0.00	0.00
Gross Profit	-0.34	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	2.84	7.25	8.03	4.79	0.17
Selling, General & Administrative	6.45	8.85	11.61	21.62	5.32
Operating Expenses	9.29	16.45	19.96	27.07	5.62
Operating Income	-9.63	-16.45	-27.42	-27.07	-5.62
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	-0.01	0.01	-0.45
Other Income/Expense	0.07	-1.03	0.01	-29.35	-0.80
Income
Income Before Tax	-9.57	-17.26	-19.96	-56.43	-6.86
Income Tax Expense	0.01	0.03	-1.49	-7.45	0.00
Net Income	-9.57	-17.29	-18.50	-48.98	-6.86
Net Income - Continuous Operations	-9.57	-17.29	-18.47	-48.98	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-9.23	-17.27	-19.52	-55.74	-5.50
EBIT	-9.57	-17.27	-19.95	-56.42	-5.62
Depreciation & Amortization	0.34	0.34	0.33	0.66	0.12
Earnings Per Share
Basic EPS	-228.00	-121.00	-13.00	-18664.00	-
Diluted EPS	-228.00	-121.00	-13.00	-18664.00	-
Basic Shares Outstanding	0.04	0.14	1.45	0.03	0.00
Diluted Shares Outstanding	0.04	0.14	1.45	0.03	0.00